Applied Genetic Technologies Corp
AGTCDelisted Dec 1, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001273636
Applied Genetic Technologies Corp was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Dec 1, 2022; 45 institutions reported holding it in 13F filings for Q3 2022, worth $3.34M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Applied Genetic Technologies Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 47 | 45 | −2 |
| Shares | 11.1M | 12.3M | +1.22M (+11.0%) |
| Value | $8.53M | $3.34M | −$5.19M (−60.9%) |
New holders (8)
Institutions that held Applied Genetic Technologies Corp at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kingdon Capital Management, L.L.C. | 1,225,000 | $333.0K | 0.10% |
| Citadel Advisors LLC | 423,709 | $115.0K | 0.00% |
| Two Sigma Investments, LP | 80,397 | $22.0K | 0.00% |
| Warberg Asset Management LLC | 30,000 | $8.00K | 0.00% |
| Two Sigma Securities, LLC | 25,296 | $7.00K | 0.00% |
| Aquatic Capital Management LLC | 21,300 | $6.00K | 0.00% |
| GWM Advisors LLC | 14,000 | $4.00K | 0.00% |
| Royal Bank of Canada | 388 | $0 | 0.00% |
Sold out (10)
Institutions that held Applied Genetic Technologies Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Sabby Management, LLC | 811,973 | $625.0K |
| Bridgeway Capital Management, LLC | 155,375 | $120.0K |
| Knoll Capital Management, LLC | 100,000 | $77.0K |
| HRT Financial LP | 69,536 | $53.0K |
| Magnetar Financial LLC | 50,000 | $39.0K |
| Shay Capital LLC | 50,000 | $39.0K |
| National Asset Management, Inc. | 20,000 | $16.0K |
| Commonwealth Equity Services, LLC | 12,064 | $9.00K |
| Captrust Financial Advisors | 3,000 | $2.00K |
| First Manhattan Co | 1,000 | $0 |